FDA Update - Search News

FDA, pancreatic cancer and expanded access

FDA expands access to pancreatic cancer drug helping patients like Ben Sasse

The Food and Drug Administration said it will allow some pancreatic cancer patients to receive access to a promising drug, even before it is officially approved for use.

· 11h · on MSN

FDA authorizes early access for experimental pancreatic cancer pill

· 12h · on MSN

FDA green lights early access to pancreatic cancer drug, daraxonrasib

· 10h

For pancreatic cancer, the FDA grants early access to the experimental drug daraxonrasib

Former U.S. Sen. Ben Sasse, R-Neb., is among those already being treated with the experimental pancreatic cancer drug.

· 11h

FDA expands access to drug helping pancreatic cancer patients

· 14h

Revolution Medicines wins FDA nod to provide early access to cancer therapy

FDA, Drug Administration

Digest more

· 1d

FDA wants to limit compounded versions of weight loss drugs

The U.S. Food and Drug Administration on Thursday proposed excluding Novo Nordisk and Eli Lilly’s ‌weight-loss drugs from a key compounding list, potentially limiting large-scale production by outsour...

· 1d · on MSN

FDA proposes curbs on mass copycats of Novo, Lilly's weight-loss drugs

· 1d

US FDA Proposes Excluding Weight-Loss Drugs From Compounding List

FDA, agitation and Alzheimer's

Digest more

· 9h

FDA approves 1st non-antipsychotic medication for agitation in Alzheimer's disease

The Food and Drug Administration (FDA) approved the drug Auvelity this week for the treatment of agitation in adults with Alzheimer's dementia.

· 1d

Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease

· 1d

US FDA approves Axsome's drug for Alzheimer's-related agitation

· 12h

FDA approves Axsome's Auvelity for Alzheimer's agitation

Axsome Therapeutics' drug Auvelity received FDA approval on Thursday to treat agitation associated with Alzheimer's disease dementia, making it the first non-antipsychotic medication cleared for the c...

STAT · 16h

Axsome wins FDA nod for Alzheimer’s agitation

· 18h

Axsome wins FDA label expansion for Auvelity in Alzheimer’s agitation

8hon MSN

Appeals court blocks FDA rule that allows women to obtain abortion drugs by mail

A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, undermining access to the method of abortion that has only grown more widespread since the US Supreme Court overturned Roe v.

23h

AstraZeneca stock falls after FDA panel votes against new cancer drug

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.

17hon MSN

US FDA taps Szarama as acting head of vaccine unit

By Kamal Choudhury May 1 (Reuters) - The U.S. Food and Drug Administration has named Katherine Szarama as the acting director of its vaccines and biologics unit, a Health and Human Services official told Reuters on Friday,

New FDA analysis says US infant formula supply is safe after testing for potential contaminants

A new analysis of chemicals in U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants, federal health officials said Wednesday. The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project — billed as the “largest and most rigorous” to date.